**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 367-29-3 |5-Fluoro-2-methylaniline | 99 | 206-689-6 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Potential Health Effects
Eye:
May cause chemical conjunctivitis and corneal damage.
Skin:
Absorption into the body may cause cyanosis (bluish discoloration of
skin due to deficient oxygenation of the blood). May cause irritation
and dermatitis. May cause cyanosis of the extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. Methemoglobinemia is characterized by dizziness,
drowsiness, headache, shortness of breath, cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood),
rapid heart rate and chocolate-brown colored blood. Overexposure may
cause methemoglobinemia.
Inhalation:
Aspiration may lead to pulmonary edema. Methemoglobinemia is
characterized by dizziness, drowsiness, headache, shortness of
breath, cyanosis (bluish discoloration of skin due to deficient
oxygenation of the blood), rapid heart rate and chocolate-brown
blood. Inhalation of aniline causes anoxia due to the formation of
methemoglobin. Inhalation at high concentrations may cause CNS
depression and asphixiation.
Chronic:
May cause methemoglobinemia, which is characterized by
chocolate-brown colored blood, headache, weakness, dizziness, breath
shortness, cyanosis (bluish skin due to deficient oxygenation of
blood), rapid heart rate, unconsciousness and possible death. Effects
may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
For methemoglobinemia, administer oxygen alone or with Methylene
Blue depending on the methemoglobin concentration in the blood.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Containers may explode
when heated.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam. Use water spray to cool fire-exposed
containers.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Sweep up, then place into a suitable container for disposal. Avoid
generating dusty conditions. Remove all sources of ignition. Use a
spark-proof tool.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Minimize dust
generation and accumulation. Do not get in eyes, on skin, or on
clothing. Empty containers retain product residue, (liquid and/or
vapor), and can be dangerous. Keep away from heat, sparks and flame.
Do not ingest or inhale. Do not pressurize, cut, weld, braze, solder,
drill, grind, or expose empty containers to heat, sparks or open
flames.
Storage:
Keep away from heat, sparks, and flame. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local explosion-proof ventilation to keep airborne levels to
acceptable levels.
Exposure Limits
CAS# 367-29-3:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: brown
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 38.00 - 40.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: 90 deg C ( 194.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Not available.
Specific Gravity/Density: Not available.
Molecular Formula: C7H8FN
Molecular Weight: 125.0611
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, dust generation, excess
heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids, acid chlorides, acid anhydrides,
chloroformates.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 367-29-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5-Fluoro-2-methylaniline -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 367-29-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 367-29-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 367-29-3 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
4-Butylbenzaldehyde, 98% (GC)
| 1200-14-2 |
|
Propionamide, 97%
| 79-05-0 |
|
4-Nitrobenzenesulfonamide, 97%
| 6325-93-5 |
|
1,1-Dichloroacetone, 98%
| 513-88-2 |
|
N,N-Dimethyltrimethylsilylamine, 97%
| 2083-91-2 |
|
3,6-Bis(2-Hydroxyethyl)-2,5-Diketopiperazine, 98%
| 50975-79-6 |
|
Hexacosanoic Acid, 98% (GC)
| 506-46-7 |
|
S-Benzyl-L-Cysteine, 99%
| 3054-01-1 |
|
Selenium, powder, 99.5+%, 200 mesh
| 7782-49-2 |
|
N-Ethyl-5-phenylisoxazolium-3'-sulfonate, 95%
| 4156-16-5 |
|
Zirconium(IV) chloride, anhydrous, 98%
| 10026-11-6 |
|
Ethyl Malonyl Chloride, Tech., 90+% (titr.)
| 36239-09-5 |
|
Saccharin, sodium salt hydrate, 99+%
| 82385-42-0 |
|
3,4-Dichloronitrobenzene, 95%
| 99-54-7 |
|
Aq 38s
| |
|
Allyl isothiocyanate, 94%
| 57-06-7 |
|
Phenanthrenequinone 95%
| 84-11-7 |
|
5-Fluoro-2-methylaniline, 99%
| 367-29-3 |
|
Magnesium Methyl Carbonate (1.8 M in DMF)
| 68-12-2 |
|
2-Chloro-3(Trifluoromethyl)Pyridine, 98+%
| 65753-47-1 |
|
5-Aminoindan, 96%
| 24425-40-9 |
|
R-(-)-1-Octen-3-Ol, 99%
| 3687-48-7 |
|
Germanium, Pieces, Irregular, 99.999%
| 7440-56-4 |
|
Di-Tert-Butyl Malonate
| 541-16-2 |
|
Adonitol, 99+%
| 488-81-3 |
|
Potassium perrhenate(vii), 99%
| 10466-65-6 |
|
Dl-norphenylephrine hydrochloride, 98%
| 15308-34-6 |
|
4-(4-Chlorophenyl)-4-hydroxypiperidine, 99 +%, crystalline
| 39512-49-7 |
|
1,5-Dihydroxynaphthalene, 99%
| 83-56-7 |
|
2,2-Diethoxyacetamide, 99%
| 61189-99-9 |
|
2,5-Dimethylpyrrolidine, 98%, Cis/Trans Mixture
| 3378-71-0 |
|
(S)-(+)-1,2-Propanediol, 99%
| 57-55-6 |
|
Harmane,98%
| 486-84-0 |
|
4,6-Dimethylpyrimidine, Tech., 93+%
| 1558-17-4 |
|
Diethylaluminum ethoxide, 25 wt% solution in toluene
| 108-88-3 |
|
Ethyl L-Lactate, 97% (GC)
| 687-47-8 |
|
5-Nitroisatin, 97%
| 611-09-6 |
|
3,5-Dihydroxybenzoic Acid, 97%
| 99-10-5 |
|
2-Acetylaminothiazole
| 2719-23-5 |
|
L-Tyrosine Methyl Ester, 98%
| 1080-06-4 |
|
n-Butyl propionate, 99+%
| 590-01-2 |
|
4-Methyl-3-Nitrobenzyl Chloride, 99%
| 84540-59-0 |
|
Methyl 4-Formylbenzoate Dimethyl Acetal, 95.7+% (GC)
| 42228-16-0 |
|
Ethyl palmitate, 98%
| 628-97-7 |
|
Hesperidin,97%
| 520-26-3 |
|
N,N'-bis(p-methoxybenzylidene)-alpha, alpha'-bi-p-toluidine, 99%
| 55290-05-6 |
|
6,7-Dihydroxy-3,4-Dihydroisoquinoline, 98%
| 4602-83-9 |
|
Benzoaza-15-crown-5, 99%
| 0-01-0 |
|
M-Hydroxycinnamic Acid, 99%, Predominantly Trans
| 14755-02-3 |
|
2,5-Dimethoxy-2,5-Dihydrofuran,99%,Cis/Trans Mixture
| 332-77-4 |
|
|